A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
| Prif Awdur: | |
|---|---|
| Awduron Eraill: | |
| Fformat: | Traethawd Ymchwil |
| Iaith: | English |
| Cyhoeddwyd: |
Brac University
2024
|
| Pynciau: | |
| Mynediad Ar-lein: | http://hdl.handle.net/10361/22045 |
| id |
10361-22045 |
|---|---|
| record_format |
dspace |
| spelling |
10361-220452024-01-02T21:02:33Z A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy Ratu, Tabassum Islam, Farzana School of Pharmacy, Brac University T-Cells Immuno-Oncology Antigen Antibody WBC Checkpoint inhibitor Tumor Cancer--Treatment. This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. Cataloged from PDF version of thesis. Includes bibliographical references (pages 39-45). The main aim of cancer immunotherapy treatment is to increase body’s own immune system to wreck the tumor cell, and to reboot the immune system, enabling it to attack the tumor cells.Cancer immunotherapy along with Adoptive T-cell, Immune checkpoint inhibitors, Combination treatment has apparently well-established method for treating malignant melanoma as well as different malignancy. Despite having immense clinical evidence over different cancers, immunotherapy treatment methods have demonstrated a little impact for cancer patients. In reality, thus it is evident that some of the patients shows relatively low responses because of immunological disorder. Fortunately, in recent times a combination of cancer immunotherapy along with other cancer treatments have shown tremendous result in clinical tests as well as the pre-clinical studies. In this article, four different types of immunotherapy techniques Adoptive T-cell, Monoclonal antibody, Immune checkpoint inhibitors, Vaccination have been reviewed. Furthermore, this project work attempts to look into the new directions in which immunotherapy is shifting and in future cancer patients can be benefitted. Tabassum Ratu B. Pharmacy 2024-01-02T04:56:44Z 2024-01-02T04:56:44Z 2022 2022-02 Thesis ID 16346022 http://hdl.handle.net/10361/22045 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 45 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
T-Cells Immuno-Oncology Antigen Antibody WBC Checkpoint inhibitor Tumor Cancer--Treatment. |
| spellingShingle |
T-Cells Immuno-Oncology Antigen Antibody WBC Checkpoint inhibitor Tumor Cancer--Treatment. Ratu, Tabassum A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. |
| author2 |
Islam, Farzana |
| author_facet |
Islam, Farzana Ratu, Tabassum |
| format |
Thesis |
| author |
Ratu, Tabassum |
| author_sort |
Ratu, Tabassum |
| title |
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy |
| title_short |
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy |
| title_full |
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy |
| title_fullStr |
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy |
| title_full_unstemmed |
A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy |
| title_sort |
review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy |
| publisher |
Brac University |
| publishDate |
2024 |
| url |
http://hdl.handle.net/10361/22045 |
| work_keys_str_mv |
AT ratutabassum areviewofnextgenerationimmunooncologyagentsforcancertherapyrecentdictationshiftsincancerimmunotherapy AT ratutabassum reviewofnextgenerationimmunooncologyagentsforcancertherapyrecentdictationshiftsincancerimmunotherapy |
| _version_ |
1814308266181656576 |